Mavrilimumab (Anti-CSF2Ra/GM-CSFRa/CD116)

製品コード：A2532         Batch: A253201

印刷

Mavrilimumab (Anti-CSF2Ra/GM-CSFRa/CD116) is a monoclonal antibody that binds to the α subunit of the granulocyte-macrophage colony stimulating factor (GM-CSF) receptor and blocks intracellular signalling downstream of GM-CSF. MW: 145.5 KD.

製品説明

CAS No. 1085337-57-0
Formulation 100 mM Pro-Ac, 20mM Arg, pH5.0
Isotype Human IgG4SP
Source CHO
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.
Shipping Shipped under low temperature conditions
Purity 99%
Protein concentration 6.39mg/ml
Endotoxin Level ＜1EU/mg

Selleckの高級品が、幾つかの出版された研究調査結果（以下を含む）で使われた：

Endothelial-Mesenchymal Transition in Tumor Microenvironment Promotes Neuroendocrine Differentiation of Prostate Cancer [ Cancer Sci, 2025, 10.1111/cas.70144] PubMed: 40706636

人間や獣医の診断であるか治療的な使用のためにでない。